These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17035932)

  • 41. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ; Koszycki D; Bradwejn J; Vaccarino FJ
    Psychoneuroendocrinology; 2000 Aug; 25(6):633-47. PubMed ID: 10840174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of pharmacological mineralocorticoid and glucocorticoid receptor blockade on the cortisol response to psychological stress.
    Deuter CE; Kaczmarczyk M; Hellmann-Regen J; Kuehl LK; Wingenfeld K; Otte C
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110905. PubMed ID: 38043634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type I glucocorticoid receptor blockade does not affect baseline or ovine corticotropin-releasing-hormone-stimulated adrenocorticotropic hormone and cortisol secretion.
    Michelson D; Chrousos GP; Gold PW
    Neuroimmunomodulation; 1994; 1(5):274-7. PubMed ID: 8528892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mineralocorticoid receptor function and cognition in health and disease.
    Wingenfeld K; Otte C
    Psychoneuroendocrinology; 2019 Jul; 105():25-35. PubMed ID: 30243757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals.
    Hinkelmann K; Wingenfeld K; Kuehl LK; Fleischer J; Heuser I; Wiedemann K; Otte C
    Neurobiol Aging; 2015 Feb; 36(2):919-24. PubMed ID: 25442112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Stress-Induced Shift From Trace to Delay Conditioning Depends on the Mineralocorticoid Receptor.
    Vogel S; Klumpers F; Kroes MC; Oplaat KT; Krugers HJ; Oitzl MS; Joëls M; Fernández G
    Biol Psychiatry; 2015 Dec; 78(12):830-9. PubMed ID: 25823790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of mineralocorticoid receptor stimulation via fludrocortisone on memory in women with borderline personality disorder.
    Wingenfeld K; Kuehl LK; Janke K; Hinkelmann K; Eckert FC; Roepke S; Otte C
    Neurobiol Learn Mem; 2015 Apr; 120():94-100. PubMed ID: 25732250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Otte C; Hinkelmann K; Moritz S; Yassouridis A; Jahn H; Wiedemann K; Kellner M
    J Psychiatr Res; 2010 Apr; 44(6):339-46. PubMed ID: 19909979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P; Eser D; Padberg F; Baghai TC; Schule C; Rötzer F; Ella R; Möller HJ; Rupprecht R
    Depress Anxiety; 2003; 18(3):140-3. PubMed ID: 14625878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic.
    Ruland T; Domschke K; Schütte V; Zavorotnyy M; Kugel H; Notzon S; Vennewald N; Ohrmann P; Arolt V; Pfleiderer B; Zwanzger P
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1677-82. PubMed ID: 26235955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M; Yassouridis A; Jahn H; Wiedemann K
    Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486.
    Clore JN; Estep H; Ross-Clunis H; Watlington CO
    J Clin Endocrinol Metab; 1988 Oct; 67(4):824-31. PubMed ID: 2843562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mineralocorticoid receptors modulate vascular endothelial function in human obesity.
    Hwang MH; Yoo JK; Luttrell M; Kim HK; Meade TH; English M; Segal MS; Christou DD
    Clin Sci (Lond); 2013 Dec; 125(11):513-20. PubMed ID: 23786536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The glucocorticoid receptor is required for experimental adrenocorticotrophic hormone-induced hypertension in mice.
    Zhang Y; Schyvens CG; Cole TJ; McKenzie KU; Vickers JJ; Whitworth JA
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1044-8. PubMed ID: 20659135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The regulatory role of glucocorticoid and mineralocorticoid receptors in pulsatile urea excretion of the gulf toadfish, Opsanus beta.
    Rodela TM; McDonald MD; Walsh PJ; Gilmour KM
    J Exp Biol; 2009 Jun; 212(Pt 12):1849-58. PubMed ID: 19483003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; Wybren De Jong
    Hypertension; 1999 May; 33(5):1201-6. PubMed ID: 10334812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia.
    Siegmund A; Köster L; Meves AM; Plag J; Stoy M; Ströhle A
    J Psychiatr Res; 2011 Mar; 45(3):339-46. PubMed ID: 20673917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming.
    Van den Berg DT; de Jong W; de Kloet ER
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E921-6. PubMed ID: 7810635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.